HRSA Releases Proposed 340B Mega-Guidance

The Health Resources and Services Administration has released its long-awaited proposed 340B Drug Pricing Program Omnibus Guidance. Healthcare organizations subject to the guidance should begin to evaluate the proposed changes and discover the potential financial and operational effects of compliance.